Elon Musk’s Nauralink Says It Has FDA Approval for Study of Brain Implants in Humans

May 26, 2023

(Wall Street Journal) – Elon Musk’s brain-implant startup Neuralink said it has been approved by the U.S. Food and Drug Administration to begin the company’s first human clinical study. The company is working on a device that will allow people to control computer interfaces with their brains. Neuralink said the devices would help restore vision and enable people with severe disabilities to move and communicate by decoding brain activity. (Read More)